sulforhodamine 101 has been researched along with g(m1) ganglioside in 2 studies
Studies (sulforhodamine 101) | Trials (sulforhodamine 101) | Recent Studies (post-2010) (sulforhodamine 101) | Studies (g(m1) ganglioside) | Trials (g(m1) ganglioside) | Recent Studies (post-2010) (g(m1) ganglioside) |
---|---|---|---|---|---|
99 | 0 | 41 | 4,120 | 73 | 677 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Agmon, V; Cestone, P; Dagan, A; Demasi, L; Gatt, S; Marchesini, S; Navon, R; Preti, A | 1 |
Agmon, V; Dagan, A; Dinur, T; Gatt, S; Khosravi, R; Marchesini, S; Navon, R | 1 |
2 other study(ies) available for sulforhodamine 101 and g(m1) ganglioside
Article | Year |
---|---|
Sulforhodamine GM1-ganglioside: synthesis and physicochemical properties.
Topics: Animals; beta-Galactosidase; Cattle; Cells, Cultured; Fluorescent Dyes; G(M1) Ganglioside; Humans; Micelles; Phosphatidylcholines; Rhodamines | 1994 |
Intracellular degradation of sulforhodamine-GM1: use for a fluorescence-based characterization of GM2-gangliosidosis variants in fibroblasts and white blood cells.
Topics: Cell Line; Fibroblasts; Fluorescence; G(M1) Ganglioside; Gangliosidoses; Humans; Leukocytes; Mutation; Rhodamines; Tay-Sachs Disease | 1996 |